Estrogen-based hormonal therapy and the risk of thrombosis in COVID-19 patients.
Corinne LaVasseurRick MathewsJenny S H WangKylee L MartensHannah Stowe McMurryShira PeressJean Michael Garcia SabileThomas KartikaIleisa OlesonJamie O LoThomas G DeLougheryOwen J T McCartyJoseph J ShatzelPublished in: European journal of haematology (2023)
These results suggest that estrogen-containing therapy is associated with a significantly increased risk of VTE in COVID-19 patients, especially in older individuals. These findings may guide provider counseling and management of patients with COVID-19 on estrogen-containing therapy.